发布求助
文献互助 智能选刊 最新文献

Drugs of The Future最新文献

筛选
英文 中文
Cefepime/taniborbactam. Fixed-dose combination, Cephalosporin beta-lactam antibiotic/beta-lactamase inhibitor, Treatment of complicated urinary tract infection 头孢吡肟/ taniborbactam。固定剂量联合，头孢菌素-内酰胺类抗生素/内酰胺酶抑制剂，治疗复杂性尿路感染
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.9.3440036
B. G. Santani, B. Leblanc, R. Thakare
{"title":"Cefepime/taniborbactam. Fixed-dose combination, Cephalosporin beta-lactam antibiotic/beta-lactamase inhibitor, Treatment of complicated urinary tract infection","authors":"B. G. Santani, B. Leblanc, R. Thakare","doi":"10.1358/dof.2022.47.9.3440036","DOIUrl":"https://doi.org/10.1358/dof.2022.47.9.3440036","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tolebrutinib. Bruton tyrosine kinase (BTK) inhibitor, Treatment of multiple sclerosis Tolebrutinib。布鲁顿酪氨酸激酶(BTK)抑制剂，治疗多发性硬化症
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.5.3400574
R. Orlandi, A. Gajofatto
{"title":"Tolebrutinib. Bruton tyrosine kinase (BTK) inhibitor, Treatment of multiple sclerosis","authors":"R. Orlandi, A. Gajofatto","doi":"10.1358/dof.2022.47.5.3400574","DOIUrl":"https://doi.org/10.1358/dof.2022.47.5.3400574","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Alzheimer's Association International Conference (AAIC) 2022. San Diego - July 31-August 4, 2022 阿尔茨海默病协会国际会议(AAIC) 2022。圣地亚哥——2022年7月31日至8月4日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.10.3487258
P. Sudha
{"title":"Alzheimer's Association International Conference (AAIC) 2022. San Diego - July 31-August 4, 2022","authors":"P. Sudha","doi":"10.1358/dof.2022.47.10.3487258","DOIUrl":"https://doi.org/10.1358/dof.2022.47.10.3487258","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66441054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pipeline on the Move - November 2022 管道在移动- 2022年11月
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.11.3509748
L. Fernández Bertolín
{"title":"Pipeline on the Move - November 2022","authors":"L. Fernández Bertolín","doi":"10.1358/dof.2022.47.11.3509748","DOIUrl":"https://doi.org/10.1358/dof.2022.47.11.3509748","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66441670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rationale of ferroportin inhibition for beta-thalassemia management 转运铁蛋白抑制治疗地中海贫血的基本原理
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.2.3335977
C. Asadov, G. Aliyeva, A. Shirinova, Z. Alimirzoyeva
{"title":"Rationale of ferroportin inhibition for beta-thalassemia management","authors":"C. Asadov, G. Aliyeva, A. Shirinova, Z. Alimirzoyeva","doi":"10.1358/dof.2022.47.2.3335977","DOIUrl":"https://doi.org/10.1358/dof.2022.47.2.3335977","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66442317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relacorilant. Glucocorticoid receptor antagonist, Treatment of Cushing syndrome, Treatment of prostate cancer, Treatment of ovarian cancer Relacorilant。糖皮质激素受体拮抗剂，库欣综合征治疗，前列腺癌治疗，卵巢癌治疗
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.3.3360407
M. Rickmann
{"title":"Relacorilant. Glucocorticoid receptor antagonist, Treatment of Cushing syndrome, Treatment of prostate cancer, Treatment of ovarian cancer","authors":"M. Rickmann","doi":"10.1358/dof.2022.47.3.3360407","DOIUrl":"https://doi.org/10.1358/dof.2022.47.3.3360407","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BIO-Europe Spring Digital 2022 - 16th Annual Partnering Conference. Virtual - March 28-31, 2022 生物欧洲春季数字2022 -第16届年度合作会议。虚拟——2022年3月28日至31日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.5.3433515
E. Cruces
{"title":"BIO-Europe Spring Digital 2022 - 16th Annual Partnering Conference. Virtual - March 28-31, 2022","authors":"E. Cruces","doi":"10.1358/dof.2022.47.5.3433515","DOIUrl":"https://doi.org/10.1358/dof.2022.47.5.3433515","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association for Cancer Immunotherapy (CIMT) - 19th Annual Meeting. Mainz/Virtual - May 10-12, 2022 癌症免疫治疗协会(CIMT)第19届年会。美因茨/虚拟- 2022年5月10日至12日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.7.3447440
R. Bandari
{"title":"Association for Cancer Immunotherapy (CIMT) - 19th Annual Meeting. Mainz/Virtual - May 10-12, 2022","authors":"R. Bandari","doi":"10.1358/dof.2022.47.7.3447440","DOIUrl":"https://doi.org/10.1358/dof.2022.47.7.3447440","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
21st RSC/SCI Medicinal Chemistry Symposium. Cambridge/Virtual - September 13-15, 2021 第21届RSC/SCI药物化学学术研讨会。剑桥/Virtual - 2021年9月13-15日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.1.3393242
D. Fernández-Forner
{"title":"21st RSC/SCI Medicinal Chemistry Symposium. Cambridge/Virtual - September 13-15, 2021","authors":"D. Fernández-Forner","doi":"10.1358/dof.2022.47.1.3393242","DOIUrl":"https://doi.org/10.1358/dof.2022.47.1.3393242","url":null,"abstract":"The Royal Chemistry Society/Society of Chemistry Industry (RSC/SCI) Medicinal Chemistry Symposium is a key symposium in the field of medicinal chemistry that takes place every 2 years at the University of Cambridge, U.K., under the auspices of the RSC and the SCI. This year, in its 21st edition, it was run as a hybrid event, simultaneously attended by both in-person and virtual attendees. Its theme was 'Improving Success', and 25 orals and 30 posters were presented. The scientific program covered recent medicinal chemistry achievements in major therapeutic areas, with a few first-time structure disclosure presentations and particular emphasis on emerging early-stage drug discovery and lead optimization strategies, including reports of successful case studies illustrating fragment-based screening and phenotypic target engagement approaches. Applications of artificial intelligence (AI), mass spectrometry and photochemistry in drug design and discovery were also highlighted. This report will cover some of the medicinal chemistry presentations delivered at the meeting.","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66440415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AACR-NCI-EORTC - 33rd International Symposium on Molecular Targets and Cancer Therapeutics. Virtual - October 7-10, 2021 AACR-NCI-EORTC -第33届分子靶点和癌症治疗国际研讨会。虚拟- 2021年10月7日至10日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.1.3393251
E. R. Domenech, P. Cole, X. Bofill
{"title":"AACR-NCI-EORTC - 33rd International Symposium on Molecular Targets and Cancer Therapeutics. Virtual - October 7-10, 2021","authors":"E. R. Domenech, P. Cole, X. Bofill","doi":"10.1358/dof.2022.47.1.3393251","DOIUrl":"https://doi.org/10.1358/dof.2022.47.1.3393251","url":null,"abstract":"The 2021 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics meeting, organized by the European Organization for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), was held in a virtual format due to the ongoing COVID-19 pandemic. Historically, 1,500 to 2,500 academics, scientists and pharmaceutical industry representatives come together at this meeting to deliver the latest updates on drug discovery, target selection, cellular and molecular biology, and early clinical trials. This year presentations were delivered both live and on-demand in oral and poster sessions. This report highlights some of the important research presented throughout the meeting.","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66440470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信